Vasundhara Rasayans Limited (BOM:538634)
India
· Delayed Price · Currency is INR 114.20
-5.80 (-4.83%)
At close: Mar 9, 2026
Vasundhara Rasayans Revenue
Vasundhara Rasayans had revenue of 74.48M INR in the quarter ending December 31, 2025, a decrease of -15.57%. This brings the company's revenue in the last twelve months to 315.86M, down -15.48% year-over-year. In the fiscal year ending March 31, 2025, Vasundhara Rasayans had annual revenue of 339.90M, down -8.18%.
Revenue (ttm)
315.86M
Revenue Growth
-15.48%
P/S Ratio
1.15
Revenue / Employee
9.57M
Employees
33
Market Cap
362.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 339.90M | -30.28M | -8.18% |
| Mar 31, 2024 | 370.18M | -9.23M | -2.43% |
| Mar 31, 2023 | 379.41M | 111.91M | 41.83% |
| Mar 31, 2022 | 267.50M | 40.71M | 17.95% |
| Mar 31, 2021 | 226.80M | 13.95M | 6.56% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Crestchem | 266.14M |
| Bacil Pharma | 5.48M |
| Ishita Drugs and Industries | 161.68M |
| Venmax Drugs and Pharmaceuticals | 44.14M |
| Supha Pharmachem | 5.27B |
| Alfavision Overseas (India) | 13.30M |
| Tyche Industries | 505.54M |
| Resonance Specialties | 899.72M |